418
Participants
Start Date
January 18, 2013
Primary Completion Date
June 24, 2014
Study Completion Date
May 14, 2021
BMS-936558 (Nivolumab)
Placebo matching BMS-936558 (Nivolumab)
Dacarbazine
Placebo matching Dacarbazine
Fundacion Cidea, Buenos Aires
Local Institution, Camperdown
Local Institution - 0006, North Sydney
Local Institution, Westmead
Coffs Harbour Health Campus, Coffs Harbour
Herlev Hospital, Herlev
Cabrini Hospital, Malvern
Princess Alexandra Hospital, Woolloongabba
Greenslopes Private Hospital, Greenslopes
Local Institution, Southport
Instituto Oncologico De Cordoba, Córdoba
Royal Adelaide Hospital, Adelaide
Odense University Hospital, Odense
Aarhus Universitetshospital, Aarhus
Laiko Hospital, Athens
Local Institution, Tlalpan
Local Institution, Genova
Metropolitan Hospital, Neo Faliro
Local Institution, Donostia / San Sebastian
Local Institution, Milan
Local Institution, Milan
Local Institution, Kiel
Local Institution, Bergamo
Local Institution, Madrid
Local Institution, Madrid
Hopital Saint Andre, Bordeaux
Hopital St Eloi, Montpellier
Local Institution, Haifa
Local Institution, Padua
Local Institution, Leon, Guanajato
Local Institution, Göttingen
Chu Grenoble - Hopital Albert Michallon, Grenoble
Local Institution, Magdeburg
Local Institution, Seville
Local Institution, Essen
Local Institution, Recklinghausen
Local Institution, Valencia
Local Institution, Meldola (fc)
Local Institution, Cologne
Local Institution, Tel Litwinsky
Local Institution, Siena
Local Institution, Mainz
Local Institution, Morelia
Chru De Lille - Hopital Claude Huriez, Lille
Local Institution, Heidelberg
Local Institution, Bari
Local Institution, Tübingen
Hopital Saint Louis, Paris
Local Institution, Napoli
Local Institution, Nuremberg
Local Institution, Jerusalem
Local Institution - 0013, Villejuif
Local Institution, Würzburg
Local Institution, Santiago
Instituto Medico Especialazado Alexander Fleming, Buenos Aires
Tom Baker Cancer Centre, Calgary
Local Institution - 0039, Vancouver
Qe Ii Health Science Centre, Halfax
Sunnybrook Health Sciences Centre, Toronto
Princess Margaret Hospital, Toronto
Local Institution - 0040, Montreal
Local Institution, Viña del Mar
Local Institution, Santiago
Local Institution - 0035, Helsinki
Local Institution, Gera
Local Institution, Roma
Local Institution, Mexico City
Local Institution, Oslo
Local Institution, Gdansk
Local Institution, Lodz
Local Institution, Warsaw
Local Institution - 0056, Barcelona
Local Institution, Gothenberg
Local Institution, Lund
Local Institution, Umeå
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY